Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
4-nitroquinoline-1-oxide
28%
5′-untranslated Region (5′-UTR)
15%
Adjusted Odds Ratio
26%
Anti-apoptotic Proteins
16%
Apoptotic Genes
14%
Basal Cell Carcinoma
15%
Benzo(a)pyrene
51%
Breast Cancer Risk
28%
Case-control Analysis
45%
Chinese Population
20%
Chromatid Breaks
41%
Chromosomal Aberrations
18%
Chronic Lymphocytic Leukemia
24%
Chronic Lymphocytic Leukemia Cells
16%
Colorectal Cancer
18%
Colorectal Cancer Risk
28%
Confidence Interval
100%
Conserved Haplotype
28%
Diol Epoxide
51%
DNA Adducts
16%
DNA Damage
16%
Esophageal Cancer
25%
Esophageal Squamous Cell Carcinoma
17%
Functional Polymorphism
31%
Gamma Irradiation
14%
Gastric Cardia Adenocarcinoma
21%
Gene Promoter
14%
Genetic Polymorphism
46%
Genotype
68%
Head-and-neck
57%
Induced Apoptosis
19%
Lung Cancer
18%
Lung Cancer Risk
30%
Matrix metalloproteinase-2 (MMP-2)
57%
Metastasis
28%
Metastatic Melanoma
24%
Mutagen Sensitivity
48%
Myeloid Cell leukemia-1 (Mcl-1)
16%
Non-melanoma Skin Cancer
22%
Odds Ratio
55%
Polymorphism
72%
Primary Lymphocytes
19%
Risk Factors
21%
Risk Reduction
23%
Skin Cancer Risk
14%
Squamous Cell Carcinoma (SqCC)
15%
Squamous Cell Carcinoma of Head
57%
Substantial Reduction
14%
TIMP-2
14%
Ultraviolet B Light
14%
Biochemistry, Genetics and Molecular Biology
Allele
8%
Carcinogenesis
26%
Case-Control Study
63%
Cell Death
14%
Chromatid
67%
Chromosomal Aberration
22%
Chromosome Instability
14%
Cigarette Smoking
7%
Comet Assay
7%
Denaturing High Performance Liquid Chromatography
5%
DNA Damage
14%
DNA Repair
5%
Dose Response
19%
Folic Acid Blood Level
14%
Gamma Radiation
28%
Gelatinase A
57%
Gene Interaction
16%
Gene Promoter
14%
Gene-Environment Interaction
10%
Genetic Polymorphism
48%
Genetic Susceptibility
9%
Genotyping
75%
Glutathione S-Transferase
14%
GSTT1
14%
Haplotype
14%
Immunity
7%
Lymphocyte
38%
Metalloendopeptidase
14%
Metalloprotease Inhibitor
14%
Metalloproteinase
14%
Metaphase
8%
MMP2
57%
Polymerase Chain Reaction
5%
Population
7%
Programmed Cell Death
32%
Promoter Region
48%
Radiosensitivity
24%
Restriction Fragment Length Polymorphism
18%
Signal Transduction
7%
Single-Nucleotide Polymorphism
8%
Smoking
14%
Statistical Test
7%
Thymidylate Synthase
14%
TIMP2
11%
Pharmacology, Toxicology and Pharmaceutical Science
4-Nitroquinoline 1-Oxide
28%
Adenocarcinoma
14%
Antiapoptotic
16%
B Lymphocyte Receptor
14%
Basal Cell Carcinoma
18%
Breast Cancer
14%
Cancer Susceptibility
16%
Carcinogen
10%
Carcinogenesis
6%
Case-Control Study
42%
Chromosome Aberration
19%
Chronic Lymphatic Leukemia
28%
Colorectal Carcinoma
14%
Cutaneous Melanoma
14%
Cyclin Dependent Kinase Inhibitor
14%
Dihydroxybenzo[a]pyrene Oxide
43%
Dose-Response Relationship
8%
Esophageal Squamous Cell Carcinoma
14%
Gelatinase A
28%
Glutathione
14%
Lung Cancer
18%
Malignant Neoplasm
23%
Melanoma
14%
Mutagenic Agent
48%
Non Melanoma Skin Cancer
25%
Phosphotransferase Inhibitor
14%
Roscovitine
5%
Skin Cancer
18%
Squamous Cell Carcinoma
49%
Thyroid Disease
5%
Thyroid Papillary Carcinoma
14%
Transferase
14%
Venetoclax
14%